Production of reactive oxygen metabolites by opsonized fungi and bacteria isolated from indoor air, and their interactions with soluble stimuli, fMLP or PMA.
Changes in the levels of free intracellular calcium ([Ca2+]i) and the production of reactive oxygen metabolites (ROM) induced by opsonized indoor air fungi and bacteria in human polymorphonuclear leukocytes (PMNL) were measured. Moreover, modification of a chemotactic peptide (fMLP)-and a tumor promoter (PMA)-induced production of ROM by opsonized fungi and bacteria were studied. The cells were exposed to graded doses of opsonized Candida sp., Aspergillus sp., Cladosporium sp., Stachybotrys sp., Penicillium sp., Paecilomyces sp., or A4 or A91 Streptomyces sp. alone, or together with fMLP or PMA. All the organisms were isolated from air samples of mold-problem buildings. None of the fungi or bacteria induced changes in [Ca2+]i or the production of ROM without opsonization with human serum. Of all opsonized fungi and bacteria, only Candida sp. elevated [Ca2+]i. All fungi and bacteria, except Paecilomyces sp. and Stachybotrys sp., markedly increased the production of ROM in PMNL. Furthermore, A91 Streptomyces sp. and Aspergillus sp. amplified fMLP-induced production of ROM. Only Candida sp. increased PMA-induced phenomen that normally occurs in the lung, was required for biological activity of the fungi and bacteria. Amplification by opsonization of fungi- or bacteria-induced leukocyte activation revealed remarkable changes between these biologically active particles. The present results suggest that many indoor air fungi and bacteria may activate leukocytes to produce oxidative stress, perhaps associated with harmful effects in exposed individuals.
Ruotsalainen
M
M
Department of Toxicology, National Public Health Institute, Kuopio, Finland.
Hyvärinen
A
A
Nevalainen
A
A
Savolainen
K M
KM
D000328:Adult; D000391:Air Microbiology; D016902:Air Pollution, Indoor / Q000009:adverse effects; D000704:Analysis of Variance; D001230:Aspergillus / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D002118:Calcium / Q000378:metabolism; D002175:Candida / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D002273:Carcinogens / Q000494:pharmacology; D002963:Cladosporium / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D005658:Fungi / Q000187:drug effects / Q000276:immunology / Q000378:metabolism*; D016257:Fura-2 / Q000737:chemistry; D006801:Humans; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000494:pharmacology; D009504:Neutrophils / Q000187:drug effects / Q000378:metabolism* / Q000382:microbiology; D009895:Opsonin Proteins / Q000009:adverse effects; D010143:Paecilomyces / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D010407:Penicillium / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D017382:Reactive Oxygen Species / Q000378:metabolism*; D013191:Stachybotrys / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D013302:Streptomyces / Q000187:drug effects / Q000276:immunology / Q000378:metabolism*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D002273:Carcinogens; D009895:Opsonin Proteins; D017382:Reactive Oxygen Species; D009240:N-Formylmethionine Leucyl-Phenylalanine; D013755:Tetradecanoylphorbol Acetate; D002118:Calcium; D016257:Fura-2